Medicare Enrolled

Dr. Kevin Longshaw, MD

Family Medicine · Dallas, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
9528 WEBB CHAPEL RD, Dallas, TX 75220
2143577311
In practice since 2006 (19 years)
NPI: 1013942374 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Longshaw from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Longshaw? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Longshaw

Dr. Kevin Longshaw is a family medicine specialist in Dallas, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Longshaw performed 310 Medicare services across 154 unique beneficiaries.

Between the years covered by Open Payments, Dr. Longshaw received a total of $13,885 from 51 pharmaceutical and/or device companies across 1037 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Longshaw is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 310 Medicare services $13,885 industry payments

Medicare Practice Summary

Medicare Utilization ↗
310
Medicare services
Bottom 38% in TX for family medicine
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
154
Unique beneficiaries
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~16 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min) 234 $78 $323
Office visit, established patient (20-29 min) 50 $52 $218
Flu vaccine, high-dose 13 $72 $90
Flu vaccine administration 13 $31 $60
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$13,885
Total received (2018-2024)
Avg $1,984/year across 7 years
Top 2% in TX for family medicine
51
Companies
1,037
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,696 (98.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$190 (1.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,530
2023
$1,976
2022
$1,957
2021
$1,673
2020
$1,482
2019
$2,506
2018
$2,762

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$2,309
Novo Nordisk Inc
$1,958
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,337
GlaxoSmithKline, LLC.
$1,194
Lilly USA, LLC
$1,128
Astellas Pharma US Inc
$545
Amarin Pharma Inc.
$513
Merck Sharp & Dohme Corporation
$448
Janssen Pharmaceuticals, Inc
$442
SANOFI-AVENTIS U.S. LLC
$413
Abbott Laboratories
$380
Amgen Inc.
$360
Merck Sharp & Dohme LLC
$355
PFIZER INC.
$345
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$226
ARBOR PHARMACEUTICALS, INC.
$186
Takeda Pharmaceuticals U.S.A., Inc.
$176
Bayer HealthCare Pharmaceuticals Inc.
$166
Bayer Healthcare Pharmaceuticals Inc.
$121
Novartis Pharmaceuticals Corporation
$99
Azurity Pharmaceuticals, Inc.
$98
Currax Pharmaceuticals LLC
$85
Exact Sciences Corporation
$81
Hikma Pharmaceuticals USA
$76
West-Ward Pharmaceuticals
$73
E.R. Squibb & Sons, L.L.C.
$72
IDORSIA PHARMACEUTICALS US INC
$61
Genentech USA, Inc.
$58
Sunovion Pharmaceuticals Inc.
$54
Gilead Sciences, Inc.
$52
Arbor Pharmaceuticals, Inc.
$52
AbbVie Inc.
$48
Dexcom, Inc.
$47
ABBVIE INC.
$43
Avvisto Therapeutics, LLC
$30
Ironwood Pharmaceuticals, Inc
$25
TheracosBio, LLC
$24
GENZYME CORPORATION
$23
Phathom Pharmaceuticals, Inc.
$18
SI-BONE, Inc.
$18
Regeneron Healthcare Solutions, Inc.
$17
Noden Pharma USA Inc
$16
Paratek Pharmaceuticals, Inc.
$15
Circassia Pharmaceuticals Inc
$15
Kowa Pharmaceuticals America, Inc.
$14
Eisai Inc.
$12
Nalpropion Pharmaceuticals LLC
$12
Nalpropion Pharmaceuticals, Inc.
$11
Allergan, Inc.
$11
DEXCOM, INC.
$11
Orexigen Therapeutics, Inc.
$11
Top 3 companies account for 40.4% of total payments
Associated products mentioned in payments ›
AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · Aimovig · Amitiza · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BEXSERO · BREO · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · Belviq · Brenzavvy · CHANTIX · CONTRAVE · CYCLOSET · Cologuard Collection Kit · DALIRESP · DEXCOM G6 TRANSMITTER · DUZALLO · Dexcom G6 Transmitter · EDARBI · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Edarbi · Edarbyclor · Epclusa · FARXIGA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GARDASIL · GLYXAMBI · INVOKANA · JANUVIA · JARDIANCE · Kerendia · LINZESS · LYRICA · Linzess · Livalo · MOUNJARO · MYRBETRIQ · Mitigare · Myrbetriq · NEXLETOL · NUZYRA · Otezla · Ozempic · PRALUENT ALIROCUMAB INJECTION · PREMARIN · PREVNAR - 13 · PREVNAR 20 · Prolia · QULIPTA · QUVIVIQ · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SIVEXTRO · SOLIQUA · SOLIQUA 100/33 · SPIRIVA · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Saxenda · TEKTURNA · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TRUMENBA · TUDORZA PRESSAIR · TZIELD · Tresiba · Trintellix · UBRELVY · UTIBRON · Uloric · Utibron · VOQUEZNA · VYNDAMAX · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · Xofluza · iFuse Implant
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for family medicine in TX.

Equivalent to $4,479 per 100 Medicare services performed
Looking for a family medicine specialist in Dallas?
Compare family medicine physicians in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
1,736
Per 100K population
66.7
County median income
$74,149
Nearest hospital
PARKLAND HEALTH & HOSPITAL SYSTEM
2.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Longshaw is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 2% of TX peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Longshaw experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Longshaw performed 234 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Longshaw receive payments from pharmaceutical companies?
Yes. Dr. Longshaw received a total of $13,885 from 51 companies across 1,037 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Longshaw's costs compare to other family medicine physicians in Dallas?
Dr. Longshaw's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Longshaw) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →